The 3rd Annual Epigenetic-Targeted Drug Discovery & Development Summit is the first and only devoted industry-specific forum exclusively focused on showcasing the latest research and pre-clinical and translational development of small-molecule, and other epigenetic modulators of gene expression, whilst providing pivotal insights to kickstart the next generation of clinically defining therapeutics and help overcome early-stage clinical trial challenges.

Attendees can expect to hear the latest discovery, preclinical and translational advancements in therapeutic interventions targeting all areas of epigenetic machinery including DNA methylation, histone post-translational modifications, chromatin remodeling, and non-coding RNAs (ncRNAs) for cancer therapies. 

Access the full event guide to learn more.